Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15147 | 659 | 34.7 | 53% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2348 | 3955 | PHOSPHOLIPIDOSIS//2 DEOXYSTREPTAMINE//AMINOGLYCOSIDES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHOSPHOLIPIDOSIS | Author keyword | 60 | 57% | 11% | 71 |
2 | DRUG INDUCED PHOSPHOLIPIDOSIS | Author keyword | 26 | 87% | 2% | 13 |
3 | CATIONIC AMPHIPHILIC DRUGS | Author keyword | 21 | 71% | 3% | 17 |
4 | LYSOSOMAL TRAPPING | Author keyword | 11 | 100% | 1% | 6 |
5 | DICATIONIC AMPHIPHILIC DRUGS | Author keyword | 8 | 100% | 1% | 5 |
6 | CATIONIC AMPHIPHILIC DRUG | Author keyword | 7 | 56% | 1% | 9 |
7 | BISMONOACYLGLYCEROPHOSPHATE | Author keyword | 5 | 47% | 1% | 8 |
8 | TILORONE | Author keyword | 5 | 35% | 2% | 11 |
9 | PH PARTITIONING | Author keyword | 4 | 75% | 0% | 3 |
10 | GLYCOSAMINOGLYCANS SULFATED | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG INDUCED PHOSPHOLIPIDOSIS | 36 | 50% | 8% | 52 |
2 | LYSOBISPHOSPHATIDIC ACID | 27 | 59% | 5% | 30 |
3 | CATIONIC AMPHIPHILIC DRUGS | 21 | 43% | 6% | 38 |
4 | CELL BASED APPROACH | 20 | 100% | 1% | 9 |
5 | INDUCED MUCOPOLYSACCHARIDOSIS | 20 | 100% | 1% | 9 |
6 | TILORONE | 17 | 72% | 2% | 13 |
7 | LIPIDOSIS | 15 | 42% | 4% | 28 |
8 | LYSOSOMAL PHOSPHOLIPIDOSIS | 15 | 88% | 1% | 7 |
9 | PREDICTING PHOSPHOLIPIDOSIS | 15 | 88% | 1% | 7 |
10 | CHLORPHENTERMINE | 13 | 69% | 2% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug-induced phospholipidosis: issues and future directions | 2006 | 101 | 92 | 46% |
Drug-induced Phospholipidosis-Pathological Aspects and Its Prediction | 2008 | 34 | 71 | 56% |
Drug-induced phospholipidosis: Are there functional consequences? | 2001 | 145 | 50 | 62% |
Drug-induced phospholipidosis | 2006 | 111 | 65 | 35% |
Antidepressant-induced lipidosis with special reference to tricyclic compounds | 2000 | 46 | 33 | 61% |
Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications | 2007 | 63 | 59 | 31% |
In vitro assays and biomarkers for drug-induced phospholipidosis | 2006 | 26 | 44 | 73% |
Medicinal Chemistry Strategies to Minimize Phospholipidosis | 2009 | 19 | 16 | 56% |
Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data | 2012 | 5 | 87 | 61% |
CATIONIC AMPHIPHILIC DRUGS AND PHOSPHOLIPID STORAGE DISORDER | 1990 | 155 | 207 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOTECHNOL BIOENGN UNIT | 2 | 67% | 0.3% | 2 |
2 | CHEMOINFORMAT MOL MODELLING | 2 | 67% | 0.3% | 2 |
3 | MULTIDISCIPLINAIRE BIOCHIM LIPIDES | 1 | 38% | 0.5% | 3 |
4 | GENET EXPLORATORY TOXICOL | 1 | 27% | 0.5% | 3 |
5 | DIPARTIMENTO DISCIPLINE CHIRURG | 1 | 17% | 0.6% | 4 |
6 | EARLY INVEST SAFETY | 1 | 50% | 0.2% | 1 |
7 | FDN HOSP LA FE | 1 | 50% | 0.2% | 1 |
8 | INSERMU870 | 1 | 50% | 0.2% | 1 |
9 | MOL CELLULAR TOXICOL GRP | 1 | 50% | 0.2% | 1 |
10 | PHARMACOLMINIST HLTH CHINA | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000154822 | TROSPECTOMYCIN//CLIN SCI AGR PRACTICES//ANAEROBIC SUSCEPTIBILITY |
2 | 0.0000133821 | UVEAL INFLAMMATION//IRIS CILIARY COMPLEX//OCULAR TISSUE |
3 | 0.0000096347 | AMIODARONE//DESETHYLAMIODARONE//AMIODARONE INDUCED THYROTOXICOSIS |
4 | 0.0000084326 | GENTAMICIN//GENTAMICIN INDUCED NEPHROTOXICITY//GENTAMICIN NEPHROTOXICITY |
5 | 0.0000083610 | HYDROXYCHLOROQUINE//PLAQUENIL//CHLOROQUINE ADVERSE EFFECTS |
6 | 0.0000077343 | STIMULATOR PROTEIN//ARRHENIUS ENERGY OF ACTIVATION//GEL TRANSFER |
7 | 0.0000071468 | LUNG METABOLIC FUNCTION//LUNG DRUG UPTAKE//PULMONARY CAPILLARY ENDOTHELIUM |
8 | 0.0000066936 | FARBER DISEASE//ASAH1//FARBER LIPOGRANULOMATOSIS |
9 | 0.0000064181 | DIBUCAINE//UNCHARGED LOCAL ANESTHETIC//SECOND DERIVATIVE SPECTROPHOTOMETRY |
10 | 0.0000063840 | HLTH SPORT SCI BIOCHEM EXERCISE NUTR//AGE DEPENDENT PHENOTYPES//AMPHIPHILIC CATION |